The activity of trastuzumab (Herceptin) has been shown to be dependent upon Her 2 neu expression levels (Pegram et al, 1998, Pegram and Slamon, 2000) and it would therefore be interesting to determine whether or not the efficacy of EGFR targeting drugs is linked to EGFR tumour level. Here, EGFR is linked to neoplasm.